Title:
Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity

dc.contributor.authorAshish Kumar Tewari
dc.contributor.authorPriyanka Srivastava
dc.contributor.authorVed Prakash Singh
dc.contributor.authorAmit Singh
dc.contributor.authorRaj Kumar Goel
dc.contributor.authorChethampadi Gopi Mohan
dc.date.accessioned2026-02-07T04:59:11Z
dc.date.issued2010
dc.description.abstractSeries of pyrazole ester prodrugs analogues have been synthesized and found to contain highly potent inhibitors of the cyclooxygenase-2 (COX-2) enzyme. The paper describes synthesis of the target pyrazole analogues. The structure of the synthesized mutual ester prodrugs (6-8c) were confirmed by 1H-, 13C-NMR mass spectroscopy (MS) and their purity were ascertained by TLC and elemental analyses. The biological in vivo evaluation of these compounds in experimental models (carrageenan-induced oedema) proved the presence of anti-inflammatory activity. Docking studies into the catalytic site of COX-2 were used to identify potential anti-inflammatory lead compounds. One lead derivative was chosen endowed with good binding energies. © 2010 Pharmaceutical Society of Japan.
dc.identifier.doi10.1248/cpb.58.634
dc.identifier.issn13475223
dc.identifier.urihttps://doi.org/10.1248/cpb.58.634
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/21769
dc.subjectCyclooxygenase
dc.subjectDocking
dc.subjectNMR
dc.subjectProdrug
dc.subjectPyrazole
dc.titleNovel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity
dc.typePublication
dspace.entity.typeArticle

Files

Collections